Spinnaker Trust’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-12,816
Closed -$1.24M – 195
2016
Q3
$1.24M Buy
12,816
+132
+1% +$12.6K 0.17% 87
2016
Q2
$1.09M Sell
12,684
-35,256
-74% -$3.16M 0.15% 95
2016
Q1
$4.17M Buy
47,940
+1,005
+2% +$89.9K 0.59% 34
2015
Q4
$5.29M Buy
46,935
+801
+2% +$86.9K 0.76% 29
2015
Q3
$4.66M Buy
46,134
+7,914
+21% +$949K 0.71% 30
2015
Q2
$4.7M Buy
+38,220
New +$4.58M 0.7% 31

Other funds holding IBB

Spinnaker Trust's IBB Position: Q4 2016 in Review

Spinnaker Trust sold out of iShares Biotechnology ETF (IBB) in Q4 2016, closing a stake of 12,816 shares — an estimated $1.24M sold.

Spinnaker Trust first reported a position in IBB in Q2 2015 and held it in 6 quarters. The position peaked at $5.29M in Q4 2015. 523 funds tracked by Wall St. Rank hold IBB as of Q4 2016.

  • Spinnaker Trust reported no remaining iShares Biotechnology ETF position as of Q4 2016 after selling out during the quarter.
  • Spinnaker Trust sold 12,816 iShares Biotechnology ETF shares in Q4 2016, an estimated $1.24M.
  • Spinnaker Trust first reported a position in iShares Biotechnology ETF in Q2 2015 and held it in 6 quarters.
  • Spinnaker Trust's iShares Biotechnology ETF position peaked at $5.29M in Q4 2015.
  • 523 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2016.

Based on Spinnaker Trust's 13F filing for Q4 2016, filed 15 Feb 2017.